Health
Saudi Arabia to begin human trials with CanSino’s Covid-19 vaccine – TRT World
Researchers say CanSino’s vaccine which is co-developed with China’s military research unit, appears to be safe and induced immune responses in most subjects.
Researchers say CanSino’s vaccine which is co-developed with China’s military research unit, appears to be safe and induced immune responses in most subjects.
Chinese vaccine maker CanSino Biologics’ sign is pictured on its building in Tianjin, China November 20, 2018.
(Reuters)
Saudi Arabia will soon begin Phase
III clinical trials on around 5,000 people for a Covid-19
vaccine developed by China’s CanSino Biologics Inc.
Last month, CanSino’s co-founder said the company was in
talks with…
-
Business14 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News14 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Noosa News14 hours agoQueen Street Mall to get a 3D digital billboard; Dutton dumps controversial plans to end flexible work; Measles alert for tourist hotspots
-
Business18 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?